Failure of Omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy

被引：0
|
作者：
Gomis, V. Soriano [1 ]
Delgado, P. Gonzalez [1 ]
Hernandez, E. Niveiro [1 ]
机构：
[1] Gen Hosp Univ Alicante, Secc Alergia, Alicante 0310, Spain
来源：
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY | 2008年 / 18卷 / 03期
关键词：
immunotherapy; omalizumab; anaphylactic reaction; bee venom;
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：225 / 226
页数：2
相关论文
共 38 条
  • [21] Distinct Epigenetic Reprogramming, Mitochondrial Patterns, Cellular Morphology, and Cytotoxicity after Bee Venom Treatment
    Uzuner, Selcen Celik
    Birinci, Esra
    Tetikoglu, Sinan
    Birinci, Ceren
    Kolayli, Sevgi
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (03) : 377 - 392
  • [22] Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy
    Korosec, P.
    Ziberna, K.
    Silar, M.
    Dezman, M.
    Smodis, N. Celesnik
    Rijavec, M.
    Kopac, P.
    Erzen, R.
    Lalek, N.
    Bajrovic, N.
    Kosnik, M.
    Zidarn, M.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (10): : 1579 - 1589
  • [23] Evolution of Api m10 specific IgE and IgG4 after one year of bee venom immunotherapy
    Pereira Santos, M. C.
    Lourenco, T.
    Pedro, E.
    Pereira Barbosa, M.
    Branco Ferreira, M.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 52 (04) : 175 - 181
  • [24] Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy
    Gonzalez Guzman, Luis Alfredo
    Garcia Robaina, Jose Carlos
    Barrios Recio, Javier
    Escudero Arias, Elena
    Linares Mata, Tania
    Cervera Aznar, Raquel
    Pinzon, Federico de la Roca
    Polo, Lissette del Carmen Miguel
    Villarroel, Luis Arenas
    Couso, Veronica P. Lopez
    Diaz, Javier Alcover
    Gil, David Rodriguez
    Pelaez, Ricardo Palacios
    Gonzalez, Francisco Javier Carballada
    VACCINES, 2023, 11 (05)
  • [25] Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC
    Xuzhang, Wendi
    Huang, Huayan
    Yu, Yongfeng
    Shen, Lan
    Li, Ziming
    Lu, Shun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [26] Life-threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure
    Badina, Laura
    Burlo, Francesca
    Belluzzi, Beatrice
    Babich, Sara
    Berti, Irene
    Barbi, Egidio
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (04)
  • [27] Salvage Endoscopic Skull Base Surgery: Another Treatment Option After Immunotherapy for Recurrent Nasopharyngeal Carcinoma
    Peng, Zhouying
    Wang, Yumin
    Fang, Yan
    Wang, Yaxuan
    Yuan, Xiaotian
    Shuai, Mingxia
    Xie, Shumin
    Fan, Ruohao
    Zhang, Hua
    Xie, Zhihai
    Jiang, Weihong
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [28] Accepting Immunotherapy After Multiline Treatment Failure: An Exploration of the Anxiety and Depression in Patients with Advanced Cancer Experience
    Xie, Qingqing
    Sun, Caixia
    Fei, Zhenghua
    Yang, Xujing
    PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 1 - 9
  • [29] Bee venom induced cytogenetic damage and decreased cell viability in human white blood cells after treatment in vitro: A multi-biomarker approach
    Gajski, Goran
    Garaj-Vrhovac, Vera
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2011, 32 (02) : 201 - 211
  • [30] INHIBITION OF BINDING OF ANTI-CD3 ANTIBODIES TO PATERNAL LYMPHOCYTES CORRELATES WITH FAILURE OF IMMUNOTHERAPY FOR TREATMENT OF RECURRENT SPONTANEOUS-ABORTIONS
    GILMANSACHS, A
    HARRIS, D
    BEER, A
    BEAMAN, KD
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1990, 17 (01) : 41 - 51
1234